Home › Therapeutic areas › Neurology › Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder (3 companies)
Companies with an active program in Attention Deficit Hyperactivity Disorder.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics | Neurology Rare | 1 | Approved | $6.96B | 15 |
| CING | Cingulate | Neurology | 1 | NDA Submitted | $61.9M | 1 |
| RVPH | Reviva Pharmaceuticals | CardiovascularDermatology+2 Rare | 1 | Phase 3 | $4.8M | 10 |
No companies match.